lung tumor
Conditions
Interventions
group G:saline 30ml
group R:0.5% ropivacaine 30ml
group RD1:30ml (0.5% ropivacaine plus 0.5ug / kg dexmedetomidine)
group RD2:30ml (0.5% ropivacaine plus 1ug / kg dexmedetomidine)
Sponsors
Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ASA classification I-II, aged 18-65 years, elective patients undergoing video-assisted thoracoscopic surgery.
Exclusion criteria
Exclusion criteria: 1. Refuse to sign the trial informed consent; 2. There is infection at the puncture site; 3. History of chronic pain and chest surgery; 4. There are obvious contraindications or allergic history to the drugs used in this study; 5. Long-term use of analgesic and sedative drugs; 6. Patients with major diseases of the heart, liver, kidney and other important organs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 15-item Quality of Recovery Rating Scale (QoR-15) Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale score;Intraoperative opioid consumption;Postoperative analgesic drug use and adverse reactions; | — |
Countries
China
Contacts
Public ContactGuo Yanxia
Affiliated Hospital of North Sichuan Medical College
Outcome results
None listed